Key Points
- Alignment Healthcare President Dawn Maroney sold 122,707 shares at an average price of $12.68, totaling approximately $1.56 million. The sale, disclosed in an SEC filing, was intended to cover tax-withholding obligations from vested equity awards and reduced her ownership by 13.38%.
- Alignment Healthcare recently exceeded quarterly expectations, reporting $0.17 in earnings per share versus the $0.13 consensus estimate and $1.34 billion in revenue, up 31.6% year over year.
- Analysts maintain a “Moderate Buy” consensus rating with an average price target of $23.60, although the stock was trading near $12.61 and several firms recently downgraded or reduced their targets.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Maroney sold 122,707 shares of the company's stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $12.68, for a total value of $1,555,924.76. Following the sale, the president directly owned 794,606 shares in the company, valued at approximately $10,075,604.08. This represents a 13.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Dawn Christine Maroney also recently made the following trade(s):
- On Monday, June 15th, Dawn Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00.
Alignment Healthcare Stock Performance
Alignment Healthcare stock opened at $12.61 on Friday. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. Alignment Healthcare, Inc. has a 12 month low of $12.39 and a 12 month high of $25.12. The company has a fifty day moving average price of $16.17 and a two-hundred day moving average price of $18.03. The company has a market cap of $2.62 billion, a PE ratio of 66.37 and a beta of 1.11.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The company had revenue of $1.34 billion for the quarter, compared to analysts' expectations of $1.31 billion. During the same period in the prior year, the company earned $0.07 earnings per share. The firm's revenue was up 31.6% compared to the same quarter last year. Research analysts expect that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on ALHC shares. Weiss Ratings reissued a "hold (c-)" rating on shares of Alignment Healthcare in a report on Tuesday, August 4th. TD Cowen reaffirmed a "buy" rating on shares of Alignment Healthcare in a report on Monday, August 3rd. Zacks Research cut Alignment Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 6th. JPMorgan Chase & Co. cut their price target on Alignment Healthcare from $26.00 to $22.00 and set an "overweight" rating on the stock in a report on Tuesday, August 4th. Finally, Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st. Seven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $23.60.
Read Our Latest Analysis on ALHC
Key Headlines Impacting Alignment Healthcare
Here are the key news stories impacting Alignment Healthcare this week:
- Positive Sentiment: CEO John Kao’s sales were conducted under a pre-arranged Rule 10b5-1 plan and were intended to cover tax-withholding obligations tied to vested equity awards, reducing the likelihood that the transactions reflect a negative view of Alignment Healthcare’s business prospects. SEC Form 4 filing
- Neutral Sentiment: Alignment Health’s annual survey reported worsening challenges for seniors related to aging in place, support gaps and medical debt. The announcement highlights issues relevant to the company’s target market but does not provide a direct change to revenue, enrollment or earnings expectations. Alignment Health senior survey
- Neutral Sentiment: Reported short interest was zero shares, with a zero-day short-interest ratio. Because the figures show no measurable short position, they provide little evidence of either bearish positioning or potential short-covering support.
- Negative Sentiment: CEO John Kao sold a combined 557,870 shares across September 10–11, worth approximately $7.1 million, reducing his reported ownership. President Dawn Maroney also sold 122,707 shares for about $1.6 million. Although the transactions were tied to tax obligations, their size and timing can weigh on sentiment and may be contributing to the stock’s decline. SEC Form 4 filing
- Negative Sentiment: Kaplan Fox announced an investigation into Alignment Healthcare for possible securities-law violations. The announcement does not establish wrongdoing, but it introduces legal and reputational uncertainty that can pressure the stock. Kaplan Fox investigation announcement
Institutional Trading of Alignment Healthcare
A number of large investors have recently modified their holdings of the company. Summit Securities Group LLC bought a new stake in Alignment Healthcare in the 4th quarter valued at about $26,000. Versant Capital Management Inc grew its position in Alignment Healthcare by 463.3% in the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company's stock worth $33,000 after purchasing an additional 1,135 shares during the last quarter. Parallel Advisors LLC grew its position in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company's stock worth $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC acquired a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $33,000. Finally, Nykredit A S acquired a new stake in shares of Alignment Healthcare in the second quarter valued at approximately $36,000. Institutional investors and hedge funds own 86.19% of the company's stock.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.
The company combines health-plan operations with proprietary technology intended to support personalized care.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
